Alessio Ottaviani

6PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesInnate immunityCell development, proliferation and deathBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.

Roselia Ciccone, Concetta Quintarelli, Antonio Camera

|Jun 09, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies.

Simona Manni, Francesca Del Bufalo, Pietro Merli

|Nov 11, 2022
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B.

Alessio Ottaviani, Federico Iacovelli, Joshua Welsch

|Mar 25, 2022
Cow Milk Extracellular Vesicle Effects on an In Vitro Model of Intestinal Inflammation.

Samanta Mecocci, Alessio Ottaviani, Elisabetta Razzuoli

|Jul 24, 2021
In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.

Bini Chhetri Soren, Jagadish Babu Dasari, Alessio Ottaviani

|Apr 30, 2021
Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB.

Alessio Ottaviani, Federico Iacovelli, Paola Fiorani

Pageof 1

Frequent Collaborators

3 joint publications

Federico Iacovelli

3 joint publications

Alessandro Desideri

2 joint publications

Maria Cecilia Quadraccia

2 joint publications

Mattia Falconi